Literature DB >> 15827865

Vascular risk factors in the Swiss population.

Krassen Nedeltchev1, Marcel Arnold, Ralf Baumgartner, Gerald Devuyst, Paul Erne, Daniel Hayoz, Roman Sztajzel, Barbara Tettenborn, Heinrich P Mattle.   

Abstract

BACKGROUND AND
PURPOSE: Identification of the population at risk of stroke remains the best approach to assess the burden of cardiovascular morbidity and mortality.
METHODS: The prevalence of hypertension (HT), hypercholesterolemia (HCh), diabetes mellitus (DM), overweight (OW), obesity (OB), tobacco use (SM), and their combinations was examined in 4,458 Swiss persons (1,741 men and 2,717 women, mean age 57.8 +/- 15 years), who volunteered for the present survey.
RESULTS: OW was the most prevalent risk factor (50 %), followed by HT (47%), HCh (33%), SM (13 %) and DM (1.6 %). The proportion of persons without risk factors (RF) was 19.9%, with 1 RF 41.5%, 2 RF 33.8%, 3 RF 4%, and 4 RF 0.9%. OW was more prevalent in men than in women (53% vs. 41%, P=0.02). More men than women aged 41-50 years and 51-60 years had HT (49 % vs. 36%, P=0.01, and 52 % vs. 42%, P=0.02). The prevalence of HCh and DM did not show any sex-related differences. HT, OW and HCh were not only the most common single risk factors, but were also most likely to aggregate with each other.
CONCLUSIONS: The majority of Swiss people have one or two vascular risk factors. OW and HT are by far most common and are likely to aggregate with each other. A small modification of these two factors would reduce the incidence of stroke and myocardial infarction significantly.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15827865     DOI: 10.1007/s00415-005-0838-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  19 in total

1.  Diet, obesity, and cardiovascular risk.

Authors:  Robert O Bonow; Robert H Eckel
Journal:  N Engl J Med       Date:  2003-05-22       Impact factor: 91.245

2.  Standards of medical care for patients with diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112

3.  Trends in mortality, morbidity, and risk factor levels for stroke from 1960 through 1990. The Minnesota Heart Survey.

Authors:  P G McGovern; G L Burke; J M Sprafka; S Xue; A R Folsom; H Blackburn
Journal:  JAMA       Date:  1992-08-12       Impact factor: 56.272

4.  American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors.

Authors:  R L Sacco; E J Benjamin; J P Broderick; M Dyken; J D Easton; W M Feinberg; L B Goldstein; P B Gorelick; G Howard; S J Kittner; T A Manolio; J P Whisnant; P A Wolf
Journal:  Stroke       Date:  1997-07       Impact factor: 7.914

5.  Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study.

Authors:  M Pyörälä; H Miettinen; P Halonen; M Laakso; K Pyörälä
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-02       Impact factor: 8.311

6.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1997-11-24

7.  Race-ethnic disparities in the impact of stroke risk factors: the northern Manhattan stroke study.

Authors:  R L Sacco; B Boden-Albala; G Abel; I F Lin; M Elkind; W A Hauser; M C Paik; S Shea
Journal:  Stroke       Date:  2001-08       Impact factor: 7.914

8.  Smoking and socioeconomic status in a population-based inner city sample of African-Americans, Latinos and whites.

Authors:  D Siegel; B Faigeles
Journal:  J Cardiovasc Risk       Date:  1996-06

9.  Risk factors for progression of common carotid atherosclerosis: the Atherosclerosis Risk in Communities Study, 1987-1998.

Authors:  Lloyd E Chambless; Aaron R Folsom; Vicki Davis; Richey Sharrett; Gerardo Heiss; Paul Sorlie; Moyses Szklo; George Howard; Gregory W Evans
Journal:  Am J Epidemiol       Date:  2002-01-01       Impact factor: 4.897

10.  Abdominal obesity and risk of ischemic stroke: the Northern Manhattan Stroke Study.

Authors:  Seung-Han Suk; Ralph L Sacco; Bernadette Boden-Albala; Jian F Cheun; John G Pittman; Mitchell S Elkind; Myunghee C Paik
Journal:  Stroke       Date:  2003-05-29       Impact factor: 7.914

View more
  6 in total

1.  Low awareness of transient ischemic attacks and risk factors of stroke in a Swiss urban community.

Authors:  Krassen Nedeltchev; Urs Fischer; Marcel Arnold; Liliane Kappeler; Heinrich P Mattle
Journal:  J Neurol       Date:  2007-03-02       Impact factor: 4.849

2.  Cardiovascular Risk Assessment and Effects on Behavior in Switzerland The Swiss Heart Foundation HerzCheck(®)/Cardio-Test(®).

Authors:  Niclas Freund; Bernhard C Friedli; Therese Junker; Martin Zimmermann; Michael J Zellweger
Journal:  Open Cardiovasc Med J       Date:  2015-02-27

3.  Neurovascular disease in Switzerland: 10-year trends show non-traditional risk factors on the rise and higher exposure in women.

Authors:  Martin Hänsel; Klaus Steigmiller; Andreas R Luft; Catherine Gebhard; Ulrike Held; Susanne Wegener
Journal:  Eur J Neurol       Date:  2022-06-22       Impact factor: 6.288

4.  Age and gender differences in the social patterning of cardiovascular risk factors in Switzerland: the CoLaus study.

Authors:  Silvia Stringhini; Brenda Spencer; Pedro Marques-Vidal; Gerard Waeber; Peter Vollenweider; Fred Paccaud; Pascal Bovet
Journal:  PLoS One       Date:  2012-11-13       Impact factor: 3.240

Review 5.  Patient adherence and the choice of antihypertensive drugs: focus on lercanidipine.

Authors:  Menno T Pruijm; Marc P Maillard; Michel Burnier
Journal:  Vasc Health Risk Manag       Date:  2008

6.  The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome.

Authors:  Mathieu Firmann; Vladimir Mayor; Pedro Marques Vidal; Murielle Bochud; Alain Pécoud; Daniel Hayoz; Fred Paccaud; Martin Preisig; Kijoung S Song; Xin Yuan; Theodore M Danoff; Heide A Stirnadel; Dawn Waterworth; Vincent Mooser; Gérard Waeber; Peter Vollenweider
Journal:  BMC Cardiovasc Disord       Date:  2008-03-17       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.